Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
LLM evaluation for thyroid nodule assessment: comparing ACR-TIRADS, C-TIRADS, and clinician-AI trust gap
0
Zitationen
10
Autoren
2025
Jahr
Abstract
Objective: To evaluate the diagnostic performance and clinical utility of advanced large language models (LLMs) -GPT-4o, GPT-o3-mini, and DeepSeek-R1- in stratifying thyroid nodule malignancy risk and generating guideline-aligned management recommendations based on structured narrative ultrasound descriptions. Methods: This diagnostic modeling study evaluated three LLMs-GPT-4o, GPT-o3-mini, and DeepSeek-R1-using standardized narrative ultrasound descriptors. These descriptors were annotated by consensus among three senior board-certified sonologists and processed independently in a stateless manner to ensure unbiased outputs. LLM outputs were assessed under both ACR-TIRADS and C-TIRADS frameworks. Two experienced clinicians (a thyroid surgeon and an endocrinologist) independently rated the outputs across five clinical dimensions using 5-point Likert scales. Primary outcomes included the area under the receiver operating characteristic curve (AUC) for malignancy prediction, and clinician ratings of guideline adherence, patient safety, operational feasibility, clinical applicability, and overall performance. Results: GPT-4o achieved the highest predictive AUC (0.898) under C-TIRADS, approaching expert-level accuracy. DeepSeek-R1, particularly with C-TIRADS, received the highest clinician ratings (mean Likert: surgeon 4.65, endocrinologist 4.63), reflecting greater trust in its practical recommendations. Clinicians consistently favored the C-TIRADS framework across all models. GPT-4o and GPT-o3-mini received lower ratings in trustworthiness and recommendation quality, especially from the endocrinologist. Conclusion: While GPT-4o demonstrated superior diagnostic accuracy, clinicians most trusted DeepSeek-R1 combined with the C-TIRADS framework for generating practical, guideline-consistent recommendations. The findings highlight the critical need for alignment between AI-generated outputs and clinician expectations, and the importance of incorporating region-specific clinical guidelines (like C-TIRADS) for the effective real-world implementation of LLMs in thyroid nodule management decision support.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.314 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.740 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.863 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.362 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.054 Zit.